FDA OKs Glaxo's inhaler, first one to combine 3 medicines
TRENTON, N.J. (AP) — The Food and Drug Administration has approved the first inhaler combining three medicines to ease breathing in patients with emphysema or chronic bronchitis.
The FDA late Monday approved sales of Trelegy Ellipta, developed jointly by GlaxoSmithKline PLC and Innoviva Inc. It contains three widely used types of medicine to prevent — rather than treat —flare-ups of the life-threatening breathing disorders.
Once daily, patients inhale the medicines through their mouth to open breathing passages and reduce inflammation that can make breathing difficult in people with chronic... read more
- 01:30 In DC primary, minimum wage is the main topic of discussion
- 22:14 Melania Trump 'hates' to see families separated at border
- 17:21 FBI agent removed from Russia probe is willing to testify
- 17:00 Trump adviser Roger Stone reveals new meeting with Russian
- 11:27 Conway says 'nobody likes' family separation policy
- 11:27 Giuliani says Trump could issue pardons after Russia probe